Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Médecins Sans Frontières Experience in the Democratic Republic of the Congo
Since 2009, nifurtimox-eflornithine combination therapy (NECT) has raised great hopes for the treatment of second-stage human African trypanosomiasis. Data from the first 18 months of NECT use in Médecins Sans Frontières programs in the Democratic Republic of the Congo confirm its good safety profile, especially among childre
